Natural product-derived compounds in clinical trials and drug approvals.
Saved in:
| Title: | Natural product-derived compounds in clinical trials and drug approvals. |
|---|---|
| Authors: | Butler MS; Centre for Superbug Solutions, Australia. m.butler2@imb.uq.edu.au., Capon RJ; Centre for Chemistry and Drug Discovery, Australia., Blaskovich MAT; Centre for Superbug Solutions, Australia. m.butler2@imb.uq.edu.au.; ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072, Australia., Henderson IR; Centre for Superbug Solutions, Australia. m.butler2@imb.uq.edu.au.; ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072, Australia. |
| Source: | Natural product reports [Nat Prod Rep] 2026 Jan 28; Vol. 43 (1), pp. 20-88. Date of Electronic Publication: 2026 Jan 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 8502408 Publication Model: Electronic Cited Medium: Internet ISSN: 1460-4752 (Electronic) Linking ISSN: 02650568 NLM ISO Abbreviation: Nat Prod Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
